Clearstead Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $671 | Buy |
|
|||||
|
2025
Q2 | $69 | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $56.6K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $239K | Hold |
|
|||||
|
2022
Q1 | $360K | Hold |
|
|||||
|
2021
Q4 | $379K | Hold |
|
|||||
|
2021
Q3 | $288K | Hold |
|
|||||
|
2021
Q2 | $223K | Hold |
|
|||||
|
2021
Q1 | $250K | Hold |
|
|||||
|
2020
Q4 | $213K | Hold |
|
|||||
|
2020
Q3 | $232K | Hold |
|
|||||
|
2020
Q2 | $254K | Hold |
|
|||||
|
2020
Q1 | $260K | Hold |
|
|||||
|
2019
Q4 | $313K | Hold |
|
|||||
|
2019
Q3 | $304K | Hold |
|
|||||
|
2019
Q2 | $427K | Hold |
|
|||||
|
2019
Q1 | $484K | Hold |
|
|||||
|
2018
Q4 | $359K | Hold |
|
|||||
|
2018
Q3 | $433K | Hold |
|
|||||
|
2018
Q2 | $587K | Hold |
|
|||||
|
2018
Q1 | $410K | Hold |
|
|||||
|
2017
Q4 | $297K | Hold |
|
|||||
|
2017
Q3 | $237K | Buy |
|